News | April 03, 2025
Asahi Kasei Life Science begins operation
Being a premium partner for pharmaceutical companies by contributing to safety and productivity of pharmaceutical manufacture
Being a premium partner for pharmaceutical companies by contributing to safety and productivity of pharmaceutical manufacture
L-HPC was independently developed by Shin-Etsu Chemical as a disintegrant for tablets
Positions Curium as leading manufacturer of Lu-177 isotope
Bio-Thera will maintain responsibility for development, manufacturing, and supply of BAT2206 and BAT2506
Collaboration combines data, identity capture and Web 3.0 crypto technologies to enhance product safety, traceability, and data integrity for AI systems
New facility will support plans to advance J&J’s portfolio and pipeline of transformational medicines for cancer, immune-mediated and neurological diseases
The inspection, conducted from March 17 to March 21, 2025, concluded with one observation in Form 483
Over the last two years, Lupin has showcased exceptional improvement in its EcoVadis scoring
The new site will increase Syngene's total single-use bioreactor capacity to 50,000L
This program aims to develop a fully human monoclonal antibody against a novel immune checkpoint protein that enables T cell activation
Subscribe To Our Newsletter & Stay Updated
